Literature DB >> 24103921

Patterns of growth in ambulatory males with Duchenne muscular dystrophy.

Nancy A West1, Michele L Yang, David A Weitzenkamp, Jennifer Andrews, F John Meaney, Joyce Oleszek, Lisa A Miller, Dennis Matthews, Carolyn DiGuiseppi.   

Abstract

OBJECTIVE: To provide weight-for-age, height-for-age, and body mass index-for-age growth reference standards for ambulatory, steroid-naïve males, ages 2-12 years, with Duchenne muscular dystrophy (DMD) and to compare these growth curves to the 2000 Centers for Disease Control and Prevention growth charts for boys, which serve as references of physical size and growth for the general male pediatric population in the US. STUDY
DESIGN: Through a multi-state population-based surveillance of individuals with muscular dystrophy, a total of 1877 weight and 1544 height measurements ascertained during 1985-2010 from 513 males with DMD were obtained retrospectively from medical record review. Cases were classified as DMD if loss of ambulation occurred before the 12th birthday or, if younger than 12 years and still ambulating, the earliest symptoms of dystrophinopathy occurred before the 6th birthday. Each growth chart was constructed using 5 percentiles: 10th, 25th, 50th, 75th, and 90th. Smoothing procedures were applied in 2 stages to the irregular plots of the empirical percentile values.
RESULTS: A set of growth curves, derived from a large cohort of male youth with DMD, are presented. These curves demonstrate that DMD males are shorter and tend to the extremes of weight and body mass index compared with the general male pediatric population in the US.
CONCLUSION: Charts representing the pattern of growth in ambulatory, steroid-naïve males with DMD can facilitate monitoring of growth and early detection of unusual growth patterns. Use of these growth standards also will assist in monitoring responses to corticosteroid treatment.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  BMI; Body mass index; CDC; Centers for Disease Control and Prevention; DMD; DMD/BMD; Duchenne muscular dystrophy; Duchenne muscular dystrophy or Becker muscular dystrophy; MD STARnet; Muscular Dystrophy Surveillance, Tracking, and Research Network

Mesh:

Year:  2013        PMID: 24103921     DOI: 10.1016/j.jpeds.2013.08.004

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  17 in total

Review 1.  Growth, pubertal development, and skeletal health in boys with Duchenne Muscular Dystrophy.

Authors:  Leanne M Ward; David R Weber
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-02       Impact factor: 3.243

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Clinical and Genetic Characteristics in Young, Glucocorticoid-Naive Boys With Duchenne Muscular Dystrophy.

Authors:  Marianela Schiava; Rachel Amos; Henriette VanRuiten; Michael P McDermott; Williams B Martens; Stephanie Gregory; Anna Mayhew; Elaine McColl; Rabi Tawil; Tracey Willis; Kate Bushby; Robert C Griggs; Michela Guglieri
Journal:  Neurology       Date:  2021-12-02       Impact factor: 9.910

4.  Obesity and Endocrine Management of the Patient With Duchenne Muscular Dystrophy.

Authors:  David R Weber; Stasia Hadjiyannakis; Hugh J McMillan; Garey Noritz; Leanne M Ward
Journal:  Pediatrics       Date:  2018-10       Impact factor: 7.124

5.  Muscular Dystrophy Surveillance, Tracking, and Research Network pilot: Population-based surveillance of major muscular dystrophies at four U.S. sites, 2007-2011.

Authors:  ThuyQuynh N Do; Natalie Street; Jennifer Donnelly; Melissa M Adams; Christopher Cunniff; Deborah J Fox; Richard O Weinert; Joyce Oleszek; Paul A Romitti; Christina P Westfield; Julie Bolen
Journal:  Birth Defects Res       Date:  2018-08-02       Impact factor: 2.344

6.  Bone Health and Endocrine Care of Boys with Duchenne Muscular Dystrophy: Data from the MD STARnet.

Authors:  David R Weber; Shiny Thomas; Stephen W Erickson; Deborah Fox; Joyce Oleszek; Shree Pandya; Yedatore Venkatesh; Christina Westfield; Emma Ciafaloni
Journal:  J Neuromuscul Dis       Date:  2018

7.  Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.

Authors:  Molly M Lamb; Nancy A West; Lijing Ouyang; Michele Yang; David Weitzenkamp; Katherine James; Emma Ciafaloni; Shree Pandya; Carolyn DiGuiseppi
Journal:  J Pediatr       Date:  2016-03-30       Impact factor: 4.406

Review 8.  A Review of MD STAR net's Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017.

Authors:  Kashika M Sahay; Tiffany Smith; Kristin M Conway; Paul A Romitti; Molly M Lamb; Jennifer Andrews; Shree Pandya; Joyce Oleszek; Christopher Cunniff; Rodolfo Valdez
Journal:  J Child Neurol       Date:  2018-10-22       Impact factor: 1.987

9.  Investigation of surface electromyography amplitude values during stair climbing task in children with Duchenne muscular dystrophy.

Authors:  Merve Bora; Ali Yalçin; Numan Bulut; Öznur Yilmaz; Ayşe Karaduman; Semra Topuz; İpek Alemdaroğlu-Gürbüz
Journal:  Neurol Sci       Date:  2021-10-04       Impact factor: 3.307

10.  Dystropathology increases energy expenditure and protein turnover in the mdx mouse model of duchenne muscular dystrophy.

Authors:  Hannah G Radley-Crabb; Juan C Marini; Horacio A Sosa; Liliana I Castillo; Miranda D Grounds; Marta L Fiorotto
Journal:  PLoS One       Date:  2014-02-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.